AtriCure, Inc. Share Price

AtriCure, Inc. Share Price

NASDAQ: ATRC | Mid Cap
$61.19
-$1.31 (-2.1%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

AtriCure, Inc. Stock Performance

Open
$62.41
Prev. Close
$62.50
Circuit Range
N/A
Day Range
$59.74 - $62.41
Year Range
$25.41 - $62.88
Volume
64,401
Average Traded
$60.60

AtriCure, Inc. Share Price Today

As of 1 November 2026, AtriCure, Inc.'s share price is $61.19. The stock opened at $62.41, compared to its previous close of $62.50. During today's trading session, AtriCure, Inc.'s share price traded between $59.74 and $62.41, with an average price of $61.07. Over the past 52 weeks, the stock has recorded a high of $62.88 and a low of $25.41. In terms of performance, AtriCure, Inc.'s share price has risen by 117.64% over the last six months and is up 77.11% on a year-on-year basis.

AtriCure, Inc. Share Price Chart

Line chart of the AtriCure, Inc. price trend over the selected period. The price fell overall, ranging from 59.76 to 61.54, ending at 61.19.
$59.74$62.41
L
Show Current Price
H

AtriCure, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.92B
PE Ratio (TTM)
295.26
Dividend Yield
0.00%
EPS (TTM)
$0.21
Revenue (TTM)
$534.53B
Return On Equity (TTM)
2.04%
Profit Margin
-2.14%
Debt to Equity
0.12
Quarterly Earnings Growth YoY
3418.52%

AtriCure, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$134.27$140.50$141.25$153.60
Net Profit-$0.27$1.76$0.11$8.96
Net Profit Margin-0.20%1.25%0.08%5.83%
Income ChangeN/A751.85%-93.75%8045.45%

AtriCure, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$330.38$399.25$465.31$534.53
Net Profit-$46.47-$30.44-$44.70-$11.45
Net Profit Margin-14.07%-7.62%-9.61%-2.14%
Income ChangeN/A34.50%-46.85%74.38%

About AtriCure, Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

AtriCure, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$56.33
$61.16
+8.56%
Sep 2026
$48.50
$56.34
+14.34%
Aug 2026
$38.45
$49.27
+30.60%
Jul 2026
$28.51
$37.73
+34.97%
Jun 2026
$27.45
$27.95
+0.99%
May 2026
$28.31
$27.68
-1.55%
Apr 2026
$28.65
$28.11
-1.45%
Mar 2026
$30.89
$28.53
-8.76%
Feb 2026
$37.20
$31.27
-15.37%
Jan 2026
$39.17
$36.95
-6.48%
Dec 2025
$35.56
$39.51
+9.49%
Nov 2025
$34.55
$36.09
+4.44%

ATRC Share Price FAQs